Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for Prevention of Neuropathic Pain in SCI
NCT00879021Phase 3Terminated
- Sponsor
- Nova Scotia Health
- Start
- Sep 2009
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in neuropathic pain comparing Pregabalin with Placebo (2 arms). Primary endpoints: Development of Neuropathic Pain at 74 weeks and Intensity of pain at 74 weeks. Started Sep 2009; status: terminated.
02
Drugs
pregabalin
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT00879021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00879021.